Skip to main content
Log in

High-dose contrast-enhanced computed tomography (CECT) with iopamidol in the detection of cerebral metastases

Tolerance of the contrast agent

  • Originals
  • Published:
Neuroradiology Aims and scope Submit manuscript

Summary

Intravenously admistered iodinated contrast media have been demostrated, since early experience with computed tomography of the brain, to improve clinical value of the procedure for detecting intracranial lesions. There is no universal agreement about the amount and the method of administration of the contrast medium. Many authors maintain that the use of large doses gives better results for the diagnosis of tumors and metastases. The purpose of this paper is to evaluate the tolerance of iopamidol administered by rapid intravenous infusion in a large number of patients undergoing contrast enhanced computed tomography to detect brain metastases. The authors examined 969 consecutive adult patients suffering from lung cancer, brain metastases have been detected in 17% of cases. Adverse reactions to contrast media occurred in 3 patients. Non ionic contrast media are recommended in this diagnostic procedure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ambrose J (1972) Computerized transverse axial scanning (tomography). Part 2: Clinical application. Br J Radiol 46: 1023

    Google Scholar 

  2. Paxton R, Ambrose J (1974) The EMI scanner. A brief review of the first 650 patients Br J Radiol 47: 530

    Google Scholar 

  3. New PF, Scott WR, Schnur JA, Davies KR, Taveras JM (1974) Computerized axial tomography with EMI scanner. Radiology 110: 109

    Google Scholar 

  4. Behrooz A-K, Fine M (1987) Application and complications of contrast media in cerebral computed tomography. In: Parvez Z, Moncada R, Sovak M (eds) Contrast media: Biologic effects and clinical application, vol III. CRC Press, Boca Raton, p 51

    Google Scholar 

  5. Ethier R, Scerwin A, Taylor S (1974) Comuterized angiotomography. The use of 100 cc hypaque 60%. Clinical and experimental results. Presented at First Int Symp Comput Axial Tomogr, Montreal

  6. Kramer RA, Janetos GP, Perlstein G (1975) An approach to contrast enhancement in computed tomography of the brain. Radiology 116: 641

    Google Scholar 

  7. Raimoko R, Majurin ML, Virtama P, Kangasneimi P (1982) Value of high contrast medium dose in brain CT. J Comput Assist Tomogr 6: 54

    Google Scholar 

  8. Shalen PK, Hayman CA, Wallace S, Handel SF (1981) Protocol for delayed contrast enhancement in computed tomography of cerebral neoplasia. Radiology 139: 397

    Google Scholar 

  9. Inaba Y, Hiratsuku H, Tsuyumu M, Fujiwara K, Takei H, Oie K, Yamaguchi T, Takasato Y (1978) Sequential delayed enhanced CT in brain tumors. Neuroradiology 16: 549

    Google Scholar 

  10. Paling MR (1979) Contrast dose for enhancement of computed tomograms of the brain. Br J Radiol 52: 62

    Google Scholar 

  11. Leonardi M, Zappoli F, Biasizzo E (1987) Lo studio CT per la ricerca di metastasi con alte dosi di mezzo di contrasto. L'efficacia. Proc Meet Tomografia computerizzata e mezzi di contrasto oggi: quando e perchè. Milano, October 23–24, 1987

  12. Scott WR (1980) Seizures: a reaction to contrast media for computed tomography of the brain. Radiology 137: 359

    Google Scholar 

  13. Lozito JC (1977) Convulsions: a complication of contrast enhancement and computerized tomography. Arch Neurol 34: 649

    Google Scholar 

  14. Witten DM, Hirsch FD, Hartman GW (1973) Acute reactions to urographic contrast medium. AJR 119: 832

    Google Scholar 

  15. Fischer HW (1980) Occurrence of seizures during cranial computed tomography. Radiology 137: 563

    Google Scholar 

  16. Langer M, Felix L, Behrends B, Eichstadt H (1987) Anwendung nichtomscher Kontrastmittel in der Computertomographie. Digit Bilddiagn 7: 25

    Google Scholar 

  17. Fischer HW, Plewes D, Violante M (1981) Contrast media, the blood-brain barrier, and cerebrail flow. Adv Neurol 30: 141

    Google Scholar 

  18. Skalpe IO (1983) Enhancement with water-soluble contrast media in computed tomography of the brain and abdomen. Survey and present state. Acta Radiol [Suppl] 366: 72

    Google Scholar 

  19. Skalpe IO, Hordvik M (1983) Comparison of side effects during cerebral computed tomography with a non ionic (iohexol) and an ionic (metrizoate) contrast medium AJNR 4: 326

    Google Scholar 

  20. Holtes S, Cronqvist S, Renaa T (1983) Contrast enhanced brain CT. Comparison between iohexol and metrizoate. Neuroradiology 24: 213

    Google Scholar 

  21. Tschakrt H (1983) Contrast medium tolerance in computed tomography. Rofo [Suppl] 118: 156

    Google Scholar 

  22. Bagg MN, Horwitz TA, Berter L (1986) Comparison of patient responses to high-and low-osmolality contrast agents injected intravenously. AJR 147: 185

    Google Scholar 

  23. Bonati P, Porrati GC, Rolandi G (1981) Iopamiro and uromiro 300 in brain CAT: a double-blind study. Rays 6: 81

    Google Scholar 

  24. Ramsey RG, Czervionke L, Dommers M, James ME, Huckman MS, Russel EJ (1987) Safety and efficacy of sodium and meglumine ioxaglate (hexabrix) and hypaque M 60% in contrast enhanced computed cranial tomographic scanning. A double blind clinical study. Invest Radiol 22: 56

    Google Scholar 

  25. Pagani JJ, Hayman LA, Bigelow RH, Libshitz HI, Lepke RA, Wallace S (1983) Diazepam prophylaxis of contrast media-induced seizures during computed tomography of patients with brain metastases. AJNR 4: 67

    Google Scholar 

  26. Neuwelt EA, Diehler JT, Vu LH, Hill SA, Michael AJ, Frankel EP (1981) Monitoring of methotrexate delivery in patients with malignant brain tumors after osmotic blood-brain barriers disruption. Ann Int Med 94: 449

    Google Scholar 

  27. Limpke KF, James G, Erhesfeld M (1970) Cerebrovascular permeability of a water-soluble contrast material, hypaque (sodium diatrizoate). Experimental study in dogs. Invest Radiol 5: 79

    Google Scholar 

  28. Hoffa JO, Archer S (1960) X-ray contrast media for cardiovascular angiography. Angiology 11: 244

    Google Scholar 

  29. Rudehili A, Gordon E, Grepe A, Widen L (1983) The epileptogenicity of neuroleptanaesthesia in patients during and after neuroradiological examinations with metrizamide. Acta Anaesthesiol Scand 27: 285

    Google Scholar 

  30. Avrahami E, Weiss-Peretz J, Cohn DF (1987) Focal epileptic activity following intravenous contrast material injection in patients with metastatic brain disease. J Neurol Neurosurg Psychiatry 50: 221

    Google Scholar 

  31. Haslam HA, Cochrene DD, Amundson GM, Johns RD (1987) Neurotoxic complications of contrast computed tomography in children. J Pediatr 111: 837

    Google Scholar 

  32. Nakstod P, Helgetreit A, Aeserud O, Ganes T, Nylerg-Hansen R (1984) Iohexol compared to metrizamide in cervical and thoracic myelography. A randomized double-blind parallel study. Neuroradiolgy 26: 474

    Google Scholar 

  33. Carchietti E, Baldassarre M, Penco T, Leonardi M (1988) Iopamidol 300-induced epilepsy. Intensive treatment and pathogenic hypothesis. A case report. Neuroradiology 30: 256

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leonardi, M., Lavaroni, A., Biasizzo, E. et al. High-dose contrast-enhanced computed tomography (CECT) with iopamidol in the detection of cerebral metastases. Neuroradiology 31, 148–150 (1989). https://doi.org/10.1007/BF00698843

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00698843

Key words

Navigation